Wasatch Advisors Inc Nurix Therapeutics, Inc. Transaction History

Wasatch Advisors Inc

  • $20.1 Billion
  • Q3 2024

A detailed history of Wasatch Advisors Inc transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Wasatch Advisors Inc holds 708,377 shares of NRIX stock, worth $14 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
708,377
Previous 858,067 17.45%
Holding current value
$14 Million
Previous $17.9 Million 11.19%
% of portfolio
0.08%
Previous 0.1%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$18.93 - $25.69 $2.83 Million - $3.85 Million
-149,690 Reduced 17.45%
708,377 $15.9 Million
Q2 2024

Aug 14, 2024
SELL
$12.02 - $21.3 $4.55 Million - $8.07 Million
-378,686 Reduced 30.62%
858,067 $17.9 Million
Q1 2024

Apr 18, 2024
SELL
$7.77 - $15.66 $11.8 Million - $23.7 Million
-1,512,992 Reduced 55.02%
1,236,753 $18.2 Million
Q4 2023

Feb 14, 2024
SELL
$4.25 - $10.71 $3.46 Million - $8.73 Million
-814,871 Reduced 22.86%
2,749,745 $28.4 Million
Q3 2023

Nov 14, 2023
SELL
$7.86 - $10.08 $2.4 Million - $3.08 Million
-305,159 Reduced 7.89%
3,564,616 $28 Million
Q2 2023

Aug 07, 2023
BUY
$8.7 - $13.28 $6.05 Million - $9.24 Million
695,773 Added 21.92%
3,869,775 $38.7 Million
Q1 2023

May 12, 2023
BUY
$8.56 - $13.26 $5.44 Million - $8.43 Million
635,370 Added 25.03%
3,174,002 $28.2 Million
Q4 2022

Feb 14, 2023
SELL
$9.86 - $14.59 $1.17 Million - $1.73 Million
-118,805 Reduced 4.47%
2,538,632 $27.9 Million
Q3 2022

Nov 14, 2022
BUY
$12.33 - $19.81 $4.86 Million - $7.81 Million
394,374 Added 17.43%
2,657,437 $34.6 Million
Q2 2022

Aug 12, 2022
BUY
$7.88 - $14.82 $5.65 Million - $10.6 Million
716,374 Added 46.32%
2,263,063 $28.7 Million
Q1 2022

May 13, 2022
BUY
$12.94 - $29.65 $4.44 Million - $10.2 Million
343,100 Added 28.51%
1,546,689 $21.7 Million
Q4 2021

Feb 15, 2022
BUY
$26.43 - $34.5 $843,962 - $1.1 Million
31,932 Added 2.73%
1,203,589 $34.8 Million
Q3 2021

Nov 12, 2021
SELL
$22.71 - $36.69 $521,376 - $842,329
-22,958 Reduced 1.92%
1,171,657 $35.1 Million
Q2 2021

Aug 12, 2021
BUY
$24.21 - $35.89 $3.85 Million - $5.7 Million
158,914 Added 15.34%
1,194,615 $31.7 Million
Q1 2021

May 10, 2021
BUY
$26.98 - $50.17 $27.9 Million - $52 Million
1,035,701 New
1,035,701 $32.2 Million

Others Institutions Holding NRIX

# of Institutions
181
Shares Held
68.1M
Call Options Held
78K
Put Options Held
53.8K
View Full List

About Nurix Therapeutics, Inc.

NRIX Quotes by TradingView
  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $935M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Wasatch Advisors Inc Portfolio

Follow Wasatch Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email